Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bitcoin News Today: Bitcoin’s Liquidity Dynamics: Small Investors Surpass Large Holders in Accumulation

Bitcoin News Today: Bitcoin’s Liquidity Dynamics: Small Investors Surpass Large Holders in Accumulation

Bitget-RWA2025/11/23 18:12
By:Bitget-RWA

- Bitcoin whales (1,000–100,000 BTC) sold 112,000 coins over 60 days, but smaller holders and short-term whales offset this with increased accumulation. - Long-term holders (>10 years) remain net buyers, while mid-cycle whales (3–5 years active) dominate selling, reflecting a generational shift in on-chain behavior. - Price dips below $100,000 coincided with rising 1,000+ BTC holder counts—a pattern seen before 2024’s ETF-driven peak—suggesting potential accumulation ahead of a rebound. - Market observers

Large Bitcoin holders are adjusting their on-chain tactics, with recent data pointing to a subtle change in the behavior of major investors. In the last two months, wallets containing between 1,000 and 10,000

offloaded 112,000 coins, . Yet, this selling activity seems to be offset by increased buying from smaller investors and short-term whales, hinting at a possible shift in market structure.

Bitcoin News Today: Bitcoin’s Liquidity Dynamics: Small Investors Surpass Large Holders in Accumulation image 0

Looking at the bigger picture, whales holding 10,000 to 100,000 BTC have

over the past half year and by 11% in the last twelve months, according to VanEck. At the same time, "minnows" with 100 to 1,000 BTC have during those respective periods. This points to a movement of capital from larger to smaller players, a trend that has accelerated as Bitcoin’s value has climbed roughly 170% in two years. Short-term figures add further detail: the 10K–100K BTC segment , suggesting opportunistic buying amid recent price swings linked to tariff-driven sell-offs.

Examining activity by holding period reveals more complexity. Whales who were active between 6 and 24 months ago have been net sellers, while those holding coins for over ten years continue to accumulate. For example, the net 30-day change for holders last active 6–24 months was -202,674 BTC,

. This contrast highlights a generational turnover, with holders active 3–5 years ago now leading as main sellers.

Recent declines in price have

. The count of wallets holding over 1,000 BTC climbed to 1,436 as dropped below $100,000, a notable change from earlier in 2025 when large holders were predominantly selling. This pattern is reminiscent of the period before the 2024 U.S. ETF debut, when large holder numbers surged ahead of a price top. : whales with more than 10,000 BTC are no longer major sellers (score near 0.5), and those with 1,000–10,000 BTC are showing slight accumulation. The most aggressive buying, however, is coming from investors with 100–1,000 BTC and wallets with less than 1 BTC, reflecting growing confidence in Bitcoin’s perceived undervaluation.

Market observers see these developments as a possible turning point. While long-term holders remain steady, short-term whales and smaller investors are positioning for a potential recovery, indicating a shift from selling to accumulating. Whether this marks the start of a lasting uptrend or just a brief pause will hinge on broader economic factors and upcoming regulatory changes.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

- Germany's SolarPlus Forum 2025 emphasized legislative clarity, funding innovation, and cross-sector collaboration to accelerate solar adoption amid evolving energy policies. - Outdated regulations and permitting hurdles were highlighted as barriers, with calls to align Bundestag reforms with market demands like gas surcharge removal by 2026. - Cement industry growth (5.7% CAGR) and green innovations support infrastructure needs, though energy cost volatility and compliance challenges persist. - Internati

Bitget-RWA2025/11/23 20:48
Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats